Degussa and Hikal sign manufacturing agreement

16-Mar-2006

The Exclusive synthesis & Catalysts business unit of Degussa AG, Dusseldorf, Germany, has announced that it has signed a long-term, non-exclusive agreement with Hikal Ltd., India, for a cooperation on the manufacture of pharmaceutical intermediates and APIs. Under this agreement Degussa will provide certain projects to Hikal. In turn, Hikal will provide manufacturing of the respective advanced intermediates and APIs for Degussa. This is the first agreement that Hikal has signed with Degussa.

Based in Nariman Point, Mumbai, with administrative offices in CBD Belapur, Navi Mumbai, Hikal has five manufacturing facilities and two R&D facilities. Offering extensive experience in contract and custom manufacturing under cGMP, Hikal began operations in 1988 with a clear vision to be a partner to national and multinational corporations as an independent source of quality fine chemicals, APIs and agrochemicals and has operated successfully for well over a decade.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!

See the theme worlds for related content

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures
View topic world

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures